09.08.2022 - COVID-19 BOOSTER UPDATE:
The NEW Moderna and Pfizer bivalent boosters both target two strains of SARS-CoV-2, the virus that causes COVID-19 – the original strain of the virus and two of the Omicron subvariants (BA.4 and BA.5), which are currently the most widespread variants globally.
Only individuals who have completed their primary
vaccination series (two doses of Pfizer or Moderna or one dose of Johnson & Johnson) are eligible to receive the bivalent booster. Those who have recently received Novavax are not yet eligible for any booster at this time.
Individuals are eligible for the bivalent booster TWO MONTHS since their last primary or booster dose(s) of Pfizer, Moderna or Johnson & Johnson. The previous monovalent booster will NO LONGER be available to persons 12 and older; the FDA is removing authorization for those boosters to reduce provider confusion for staff administering vaccines.
The Pfizer bivalent booster is currently authorized for ages 12 and older while Moderna’s is currently authorized for 18 years of age and older. Individuals may choose to receive either the Pfizer or Moderna bivalent booster, regardless of which primary series vaccine or original booster dose they had previously.
We have the Pfizer bivalent booster vaccine currently available at our Cassville office. Call us at 417-847-2114 if you have any questions.
Original source can be found here.
Alerts Sign-up